Praxis für HNO und Allergologie Dr. Yury Yarin — Clinical Trial Site

10 Registered trials

2 Currently recruiting

Organisation

Praxis für HNO und Allergologie Dr. Yury Yarin

Location

Dresden, Germany

Identifier

ORL-000002994

Address

Overbeckstraße 33, 01139, Germany

Departments

Facharzt fuer HNO und Allergologie
HNO, Allergology
N/A
Private practice

Clinical trials at this site (10)

Search interface

Randomised efficacy and safety clinical trial of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by … Pending

2023-507427-28-00 seasonal allergic rhinitis and/or rhinoconjunctivitis 5
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy Pending

2024-517520-19-00 Patients with moderate-to-severe allergic rhinitis / rh 10
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from house dust mite allergy. A prosp… Recruiting

2025-523119-12-00 Patients with moderate-to-severe allergic rhinitis / rh 10 2026-04-02
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CO… Recruiting

2023-508760-29-00 Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) 5 2024-10-21
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy Ended

2024-517524-18-00 Patients with moderate-to-severe allergic rhinitis / rh 10 2025-10-22
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from grass pollen allergy Ended

2024-517521-25-00 Patients with moderate-to-severe allergic rhinitis/rhin 10 2025-10-20
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from birch pollen allergy Ended

2024-517515-75-00 Patients with moderate-to-severe allergic rhinitis / rh 10 2025-07-17
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from house dust mite allerg… Ended

2024-517014-15-00 Moderate-to-severe allergic rhinitis / rhino-conjunctiv 10 2025-05-07
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended

2024-515717-17-00 birch pollen-induced allergic rhinitis birch pollen-ind 5 2024-10-28
A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered sub… Ended

2023-508013-16-00 Birch pollen induced allergic rhinitis or rhinoconjunct 5 2024-02-26